Skip to main content
Figure 2 | Diagnostic Pathology

Figure 2

From: Use of anchorchip-time-of-flight spectrometry technology to screen tumor biomarker proteins in serum for small cell lung cancer

Figure 2

Scatter plot of the top two peaks on basis of which the classification patient-control group was made: The x-axis represented 1865.79 Da and the y-axis represented 1778.67 Da in order to observe their ability of sample distribution. The farrago area was small and it showed that they could distinguish SCLC (red) from controls (green) effectively.

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us